Macrophage innate immune signaling pathways

Macrophage innate immune signaling pathways represent the integrated network of molecular cascades that govern how macrophages sense and respond to environmental stimuli. These pathways are primarily triggered by the engagement of Pattern Recognition Receptors (PRRs), including Toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs), which detect conserved microbial motifs or endogenous danger signals (Akira et al., 2006). Activation of these receptors initiates downstream signaling through key adapter proteins and kinases, such as MyD88, TRIF, and MAP kinases, ultimately leading to the nuclear translocation of transcription factors like NF-κB and IRFs (Medzhitov, 2007). This process drives the expression of inflammatory mediators, phagocytic machinery, and co-stimulatory molecules essential for host defense. In many diseases, such as rheumatoid arthritis, Crohn's disease, and various cancers, these pathways become chronically activated or maladaptive, contributing to tissue damage and disease progression (Wynn et al., 2013). Consequently, specific components of these pathways are major targets for therapeutic intervention, utilizing monoclonal antibodies and small molecule inhibitors to dampen excessive inflammation or repolarize macrophages within the tumor microenvironment (Mantovani et al., 2017).

Other names

Macrophage activation pathwaysInnate immune signaling in macrophagesMacrophage PRR signalingMacrophage inflammatory signaling

Therapeutic agents modulate macrophage innate immune signaling by either blocking the initial recognition of stimuli (e.g., TLR antagonists), inhibiting intracellular signal transduction (e.g., JAK inhibitors), or neutralizing the resulting effector cytokines (e.g., TNF or IL-6 inhibitors) to reduce pathological inflammation or alter macrophage polarization.